EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tea Consumption and Liver Cancer: A Population-Based Case–Control Study in Eastern China

Xing Liu, Aileen Baecker, Ming Wu, Jinyi Zhou, Ziyi Jin iD, Lina Mu, Na He, Jianyu Rao, Qing-Yi Lu iD, Liming Li, Jin-Kou Zhao iD, Zuo-Feng Zhang iD

Nutrients · 2025

DOI: 10.3390/nu17162647 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Xing Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, CA 90095 CA, USA. Hauptthemen laut MEDLINE: Tea, Liver Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, the Jiangsu Provincial Health Department, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Identifying dietary factors influencing liver cancer is crucial for developing preventive measures. While tea polyphenols have demonstrated cancer-preventive activities in animal models, the evidence in humans is not definitive. This study aims to explore the association between tea consumption and liver cancer, as well as the interaction between tea drinking and other risk factors, in China, a country with a high incidence of liver cancer and substantial tea consumption.

Methods

A population-based case–control study was conducted in Jiangsu Province from 2003 to 2010. Socio-demographic data, history of tea consumption, and serum markers of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections were evaluated. Unconditional logistic regression was used to examine the associations between tea consumption and the odds of liver cancer. Potential interactions between tea consumption and other major liver cancer risk factors were assessed.

Results

A total of 2011 incident liver cancer cases and 7933 controls were included in the analysis. Regular tea drinking showed an inverse association with the risk of liver cancer compared with those who never drank tea (OR: 0.79; 95% CI: 0.63–0.99). Current tea drinking showed an inverse association with liver cancer (OR: 0.51; 95% CI: 0.39–0.66), while former tea drinking showed a positive association (OR: 3.56; 95% CI: 2.42–5.23). Current tea consumption was inversely associated with liver cancer incidence among both hepatitis B surface antigen (HBsAg) positive (OR: 0.45; 95% CI: 0.28–0.73) and HBsAg negative participants (OR: 0.51, 95% CI: 0.36–0.73), among both never and ever tobacco smokers, ever alcohol drinkers (OR: 0.46; 95% CI: 0.33–0.63), and among those without family history of liver cancer. Multiplicative and additive interactions were observed between tea drinking and HBsAg, alcohol consumption, and history of raw water drinking.

Conclusions

Tea consumption is inversely associated with the development of primary liver cancer, with potential interactions involving HBV infection, alcohol consumption, and raw (unsafe) water drinking. Increasing tea consumption—particularly among high-risk populations such as individuals who consume alcohol—may serve as an additional preventive measure for liver cancer. This should be considered alongside established strategies, including HBV vaccination, alcohol cessation, and avoidance of drinking raw water, to help reduce liver cancer risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TeaLiver NeoplasmsHumansCase-Control StudiesMaleChinaFemaleMiddle AgedRisk FactorsAdultAgedHepatitis BIncidence

Stichwörter der Autor:innen

Chinese populationcase–control studyinteractionliver cancertea

Substanzen

Tea

Autor:innen und Institutionen

  • Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, CA 90095 CA, USA.
  • Department of Epidemiology, School of Public Health, Fudan University, Shanghai 200032, China.
  • Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA 91101, USA.
  • Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
  • Department of Social and Preventive Medicine, School of Public Health and Health Professions, University at Buffalo, The State University of New York, Buffalo, NY 14214, USA.
  • Department of Pathology and Laboratory Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA.

ORCID-Profile: Ziyi Jin, Qing-Yi Lu, Jin-Kou Zhao, Zuo-Feng Zhang

Förderung

  • NIH HHS
  • the Jiangsu Provincial Health Department
  • NCI NIH HHS
  • the Alper Research Program of Environmental Genomics of the UCLA Jonsson Comprehensive Cancer Center
  • FIC NIH HHS
  • Jiangsu Provincial Health Department
  • NIH National Cancer Institute, Department of Health and Human Services
  • NIH/Fogarty

Zitieren

APA

Liu, X., Baecker, A., Wu, M., Zhou, J., Jin, Z., Mu, L., He, N., Rao, J., Lu, Q. Y., Li, L., Zhao, J. K., & Zhang, Z. F. (2025). Tea Consumption and Liver Cancer: A Population-Based Case–Control Study in Eastern China. Nutrients. https://doi.org/10.3390/nu17162647

Vancouver

Liu X, Baecker A, Wu M, Zhou J, Jin Z, Mu L, et al. Tea Consumption and Liver Cancer: A Population-Based Case–Control Study in Eastern China. Nutrients. 2025. doi:10.3390/nu17162647

BibTeX
@article{Liu2025,
  author = {Liu, Xing and Baecker, Aileen and Wu, Ming and Zhou, Jinyi and Jin, Ziyi and Mu, Lina and He, Na and Rao, Jianyu and Lu, Qing-Yi and Li, Liming and Zhao, Jin-Kou and Zhang, Zuo-Feng},
  title = {Tea Consumption and Liver Cancer: A Population-Based Case–Control Study in Eastern China},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17162647}
}
Kostenlos starten →